Literature DB >> 23468360

Combined transoral robotic surgery and endoscopic endonasal approach for the resection of extensive malignancies of the skull base.

Ricardo L Carrau1, Daniel M Prevedello, Danielle de Lara, Kasim Durmus, Enver Ozer.   

Abstract

BACKGROUND: Oncologic resection of the clivus, nasopharynx, craniovertebral junction, and infratemporal fossa is a challenging endeavor because of their complex and protected anatomy. Our goals were to design a cadaveric model and identify advantages and limitations of combining the transoral robotic surgery (TORS) and endoscopic endonasal approach (EEA) techniques.
METHODS: Cadaveric specimens were dissected using a da Vinci surgical robot and endoscopic endonasal instruments in a fashion that mimicked our operating room environment. We then applied these techniques clinically.
RESULTS: EEA was performed to provide a detailed dissection of the infratemporal fossa, nasopharynx, posterior skull base (clivus), and craniovertebral junction. Using TORS, we dissected the parapharyngeal space, infratemporal fossa, and nasopharynx below the eustachian tube, which represented a transition zone that delineated the most effective resection field of each approach.
CONCLUSIONS: TORS and EEA seem to be complementary techniques; thus, their combined use seems advantageous for selected advanced tumors in these complex areas.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  adenoid cystic carcinoma; chordoma; endoscopic surgery; skull base surgery; transoral robotic surgery

Mesh:

Year:  2013        PMID: 23468360     DOI: 10.1002/hed.23238

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

Review 1.  Comprehensive review on rhino-neurosurgery.

Authors:  Werner Hosemann; Henry W S Schroeder
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 2.  Modern endoscopic skull base neurosurgery.

Authors:  Rafael Martinez-Perez; Luis C Requena; Ricardo L Carrau; Daniel M Prevedello
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

3.  Transoral robotic-assisted skull base surgery to approach the sella turcica: cadaveric study.

Authors:  Dorian Chauvet; Antoine Missistrano; Mikaël Hivelin; Alexandre Carpentier; Philippe Cornu; Stéphane Hans
Journal:  Neurosurg Rev       Date:  2014-05-22       Impact factor: 3.042

4.  Development of a new endoscope holder for head and neck surgery--from the technical design concept to implementation.

Authors:  Julia Kristin; Armin Kolmer; Peter Kraus; Robert Geiger; Thomas Klenzner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-24       Impact factor: 2.503

Review 5.  [Robot-assisted surgery in the head and neck region].

Authors:  T K Hoffmann; D T Friedrich; P J Schuler
Journal:  HNO       Date:  2016-09       Impact factor: 1.284

6.  [Robotics in otorhinolaryngology, head and neck surgery].

Authors:  F Böhm; J Greve; R Riepl; T K Hoffmann; P J Schuler
Journal:  HNO       Date:  2021-07-16       Impact factor: 1.284

Review 7.  [Robot-assisted head and neck surgery].

Authors:  P J Schuler; F Boehm; L R Schild; J Greve; T K Hoffmann
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

8.  Potential Surgical Exposure of the Parapharyngeal Internal Carotid Artery by Endonasal, Transoral, and Transcervical Approaches.

Authors:  Kangsadarn Tanjararak; Smita Upadhyay; Thanakorn Thiensri; Jun Muto; Boonsam Roongpuvapaht; Daniel M Prevedello; Ricardo L Carrau
Journal:  J Neurol Surg B Skull Base       Date:  2017-10-13

Review 9.  Transpalatal Approaches to the Skull Base and Reconstruction: Indications, Technique, and Associated Morbidity.

Authors:  Nyall R London; Jimmy Y W Chan; Ricardo L Carrau
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

10.  Transoral robotic-assisted surgery for the approach to anterior cervical spine lesions.

Authors:  Gabriele Molteni; Marco Giuseppe Greco; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.